What is the placebo effect?
The placebo effect is the change recorded in a person after they receive a neutral intervention with no pharmacological action, where that change exceeds the change seen in a group receiving no intervention at all. In other words, feeling better can come from the person's own expectations, context, and beliefs, not from the pill or ritual itself. This is a widely documented phenomenon in psychology and experimental medicine, but it is also one of the most misunderstood concepts. The key point to grasp from the start: placebo can affect how a person perceives their condition, but it does not affect the disease process itself inside the body.
The word "placebo" in Latin means "I shall please." In clinical trials, placebo is used to create a control group: one group receives the intervention being tested, another receives something identical in appearance but with no active ingredient. Any change in the control group is called the "placebo response," while the difference between that response and the results of a group receiving no intervention is what is called the "placebo effect." Separating these two concepts matters greatly, because most of the relief people attribute to placebo may actually come from entirely different factors.
Why must the placebo response be separated from the placebo effect?
The placebo response bundles many things together: the body healing over time, the disease progressing in a different direction, errors in trial recording, and the tendency to regress toward the mean. Regression to the mean is a statistical effect: when a person is measured at a moment when symptoms are worse or better than their usual level, the next measurement tends to return closer to the average, regardless of what they do. Without separating this out, it is easy to wrongly conclude that a ritual or pill produced something.
What can placebo affect?
Reviews and meta-analyses show placebo affects subjective and continuous outcomes most clearly, especially the experience of pain and some accompanying symptoms. In other words, it changes how a person reports and perceives their condition, not the disease itself. A 2001 meta-analysis examined trials across 40 different medical conditions and concluded that the only condition where placebo showed a significant effect was pain. A 2010 Cochrane review by Asbjørn Hróbjartsson and Peter C. Gøtzsche also found that the placebo effect appeared mainly in subjective, continuous scales and in the treatment of pain and related conditions; the authors concluded they "did not find that placebo interventions have important clinical effects in general." This interpretation has been contested, particularly on methodological grounds, so it remains a point of ongoing debate among researchers.
On the other side, some recent studies report placebo is associated with improved motor function in Parkinson's patients, with certain immune and endocrine parameters, with organ functions governed by the autonomic nervous system, and with athletic performance. These results should be read cautiously: they show a more complex picture than the conclusion that "placebo is nothing," but they do not turn placebo into a method that eliminates disease.
| Outcome category | Does placebo clearly affect it? | Notes |
|---|---|---|
| Pain perception, nausea | Yes, documented in many studies | Subjective outcome, depends on how patients report |
| Anxiety, fatigue, general feeling | Often documented | Hard to separate from expectation and context |
| The disease itself, disease progression | No | 2010 Cochrane review found no effect on disease |
| Biological parameters like blood pressure, immune, endocrine | Signals in some studies | Still debated, needs more data |
| Motor function in Parkinson's | Signals in recent research | Does not mean the disease is eliminated |
Why can a ceremony make someone feel lighter?
A ceremony, a prayer ritual, or a solemnly presented therapy creates exactly the conditions the literature describes as strengthening the placebo effect: positive expectation, a solemn context, and the care of the practitioner. Research shows that if the person giving the placebo shows interest, friendliness, empathy, or has high expectations of the outcome, the placebo has a stronger effect. The method of administration also matters: taking more pills is stronger than fewer, capsules are stronger than tablets, and injections are stronger than capsules.
This explains why after a ceremony, a person may feel lighter, less tense, less headache, or sleep more easily. Those feelings are real to the person experiencing them and should not be dismissed as if they were imagined. But a clear distinction is needed: feeling lighter does not mean the process inside the body has been resolved. A tumor does not shrink because of a ceremony. An infection is not eliminated because of belief. A chronic disease does not stop progressing because the patient feels calmer for a few days.
Does every ritual produce this effect?
There is no basis to say every ritual produces a placebo effect, and no basis to say the effect is the same in everyone. Response levels vary by individual. Some studies suggest optimistic people tend to show stronger placebo responses, while people with high anxiety levels are more prone to the nocebo effect. Nocebo is the flip side: when a person expects something harmful, they may report negative effects or worsening symptoms even though what they received is completely inert. Placebo can also cause side effects similar to real ones, and withdrawal symptoms have been recorded after stopping placebo, for example in the Women's Health Initiative research on menopausal hormone therapy.
What factors make the effect stronger or weaker?
Many factors are documented as influencing the strength of the placebo effect. A review in JAMA Psychiatry found that in antipsychotic trials, the change in the placebo group increased significantly from 1960 to 2013, and the authors suggested several possible causes, including inflated baseline scores and the enrollment of fewer severely ill patients. Another analysis in the journal Pain in 2015 found placebo responses increased significantly in neuropathic pain trials in the US from 1990 to 2013, possibly related to trials becoming larger and longer. These are observations about trends in trial data, not evidence that ritual or belief can replace treatment.
One notable line of research is open-label placebo, where patients are told clearly that what they are receiving is inert. Some trials show open-label placebo can have positive effects compared to no intervention, but a review noted these trials were conducted with small numbers of participants, so interpretation should be cautious until better-controlled trials exist. An updated systematic review and meta-analysis in 2021 based on 11 studies also found an overall significant effect, though slightly smaller, and noted that "research on open-label placebo is still in its early stages."
Why is measuring the placebo effect difficult?
Measuring the magnitude of the placebo effect is very difficult because many confounding factors exist. A person may feel better after receiving placebo because the disease heals on its own or symptoms change naturally, and this can be ruled out by comparing a placebo group with a no-intervention group. But distinguishing a true placebo effect from response bias, observer bias, and other methodological errors in trials is harder, because a trial comparing placebo with no intervention would not be blinded. Hróbjartsson and Gøtzsche themselves argued that even if placebo has no true effect, differences between the placebo group and the no-intervention group would still be recorded due to bias linked to lack of blinding.
Another measurement approach is the "open or hidden" study design: some patients receive pain medication and are told they are receiving it, others receive the same medication but do not know. Such studies show pain medication has a significantly stronger effect when patients know they are receiving it. This is fairly clear evidence for the role of expectation, but it is still about pain perception, not about eliminating the disease.
The depression case: an example showing the debate continues
In 2008, a meta-analysis led by psychologist Irving Kirsch, based on US Food and Drug Administration data, concluded that 82% of the response to antidepressants was due to placebo. However, other authors expressed doubt about the methodology and interpretation, particularly the use of 0.5 as the threshold for effect size. A re-analysis and full recalculation on the same dataset argued that Kirsch's study had "important errors in calculation"; this group concluded that while a large proportion of placebo response is due to expectation, that does not hold for the active drug. Another meta-analysis found 79% of depressed patients on placebo remained well for 12 weeks after 6 to 8 weeks of successful initial treatment, compared to 93% in the antidepressant group; however, in the maintenance phase, the placebo group relapsed significantly more often. This is an example showing the same dataset can lead to different conclusions depending on statistical handling, and readers should be cautious about any overly definitive claim in either direction.
Ethics and limits of using placebo
Deliberately giving placebo to a person when effective treatment exists is a complex biomedical ethics issue. Placebo-controlled trials can provide information about the efficacy of an intervention, but at the same time deny some patients what may be the best available treatment. Informed consent is usually required for a study to be considered ethical, including informing participants that some will receive placebo. In clinical practice, using placebo without the patient's knowledge also raises issues about honesty in the doctor-patient relationship and about bypassing informed consent.
What to remember when evaluating an experience for yourself
Feeling lighter after a ceremony, a prayer session, or a psychological therapy is an experience that deserves respect, and the placebo literature shows it can have a real psychological basis. But at the same time, a clear boundary must be kept: that feeling is not evidence that the ritual affected what is happening inside the body. If a person feels better mentally, that can be a real benefit to quality of life, and there is no need to deny it. If a person believes they have eliminated a disease through ritual or belief, that is when objective medical data is needed to check.
Every health problem, whether mild or severe, needs to be examined and evaluated at a medical facility by a qualified professional. Rituals, beliefs, and spiritual practices can accompany treatment, can help a person feel calmer, but cannot replace diagnosis and treatment. Do not delay getting checked because of a belief that a ritual will handle the problem. And if a person is taking medication or following a treatment protocol, they should not stop or change it on their own because they feel lighter after a psychological experience.
Summary
The placebo effect is a widely documented psychological phenomenon that can affect subjective experience such as pain, anxiety, and fatigue, but does not affect the disease itself. Feeling lighter after a ceremony is real to the person experiencing it, and can be partly explained by expectation, context, and care. However, major reviews still show placebo does not eliminate disease, and measuring this effect still faces many methodological difficulties. The reasonable approach is to respect subjective experience while maintaining the principle: every health problem needs to be examined at a medical facility.
